102 related articles for article (PubMed ID: 35973732)
1. Markers of Kidney Tubular Secretion and Risk of Adverse Events in SPRINT Participants with CKD.
Bullen AL; Ascher SB; Scherzer R; Garimella PS; Katz R; Hallan SI; Cheung AK; Raphael KL; Estrella MM; Jotwani VK; Malhotra R; Seegmiller JC; Shlipak MG; Ix JH
J Am Soc Nephrol; 2022 Oct; 33(10):1915-1926. PubMed ID: 35973732
[TBL] [Abstract][Full Text] [Related]
2. Kidney tubule health, mineral metabolism and adverse events in persons with CKD in SPRINT.
Ascher SB; Scherzer R; Estrella MM; Berry JD; de Lemos JA; Jotwani VK; Garimella PS; Malhotra R; Bullen AL; Katz R; Ambrosius WT; Cheung AK; Chonchol M; Killeen AA; Ix JH; Shlipak MG;
Nephrol Dial Transplant; 2022 Aug; 37(9):1637-1646. PubMed ID: 34473302
[TBL] [Abstract][Full Text] [Related]
3. Estimated Kidney Tubular Secretion and Kidney, Cardiovascular, and Mortality Outcomes in CKD: The Systolic Blood Pressure Intervention Trial.
Ascher SB; Shlipak MG; Katz R; Bullen AL; Scherzer R; Hallan SI; Cheung AK; Raphael KL; Estrella MM; Jotwani VK; Seegmiller JC; Ix JH; Garimella PS
Kidney Med; 2022 Dec; 4(12):100546. PubMed ID: 36507053
[TBL] [Abstract][Full Text] [Related]
4. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.
Malhotra R; Katz R; Jotwani V; Ambrosius WT; Raphael KL; Haley W; Rastogi A; Cheung AK; Freedman BI; Punzi H; Rocco MV; Ix JH; Shlipak MG
Clin J Am Soc Nephrol; 2020 Mar; 15(3):349-358. PubMed ID: 32111704
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of Kidney Tubule Health, CKD Progression, and Acute Kidney Injury in SPRINT (Systolic Blood Pressure Intervention Trial) Participants.
Bullen AL; Katz R; Jotwani V; Garimella PS; Lee AK; Estrella MM; Shlipak MG; Ix JH
Am J Kidney Dis; 2021 Sep; 78(3):361-368.e1. PubMed ID: 33857535
[TBL] [Abstract][Full Text] [Related]
6. Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease.
Jotwani VK; Lee AK; Estrella MM; Katz R; Garimella PS; Malhotra R; Rifkin DE; Ambrosius W; Freedman BI; Cheung AK; Raphael KL; Drawz P; Neyra JA; Oparil S; Punzi H; Shlipak MG; Ix JH;
Am J Nephrol; 2019; 49(5):346-355. PubMed ID: 30939472
[TBL] [Abstract][Full Text] [Related]
7. Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial.
Garimella PS; Lee AK; Ambrosius WT; Bhatt U; Cheung AK; Chonchol M; Craven T; Hawfield AT; Jotwani V; Killeen A; Punzi H; Sarnak MJ; Wall BM; Ix JH; Shlipak MG
Eur Heart J; 2019 Nov; 40(42):3486-3493. PubMed ID: 31257404
[TBL] [Abstract][Full Text] [Related]
8. Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.
Malhotra R; Craven T; Ambrosius WT; Killeen AA; Haley WE; Cheung AK; Chonchol M; Sarnak M; Parikh CR; Shlipak MG; Ix JH;
Am J Kidney Dis; 2019 Jan; 73(1):21-30. PubMed ID: 30291012
[TBL] [Abstract][Full Text] [Related]
9. Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.
Tuttle KR; Dworkin LD; Henrich W; Greco BA; Steffes M; Tobe S; Shapiro JI; Jamerson K; Lyass A; Pencina K; Massaro JM; D'Agostino RB; Cutlip DE; Murphy TP; Cooper CJ
Clin J Am Soc Nephrol; 2016 Jul; 11(7):1180-1188. PubMed ID: 27225988
[TBL] [Abstract][Full Text] [Related]
10. Tubular Biomarkers and Chronic Kidney Disease Progression in SPRINT Participants.
Jotwani V; Garimella PS; Katz R; Malhotra R; Bates J; Cheung AK; Chonchol M; Drawz PE; Freedman BI; Haley WE; Killeen AA; Punzi H; Sarnak MJ; Segal MS; Shlipak MG; Ix JH;
Am J Nephrol; 2020; 51(10):797-805. PubMed ID: 32906135
[TBL] [Abstract][Full Text] [Related]
11. Association of Urinary Dickkopf-3 Levels with Cardiovascular Events and Kidney Disease Progression in Systolic Blood Pressure Intervention Trial.
Peschard VG; Scherzer R; Katz R; Chen TK; Bullen AL; Campos K; Estrella MM; Ix JH; Shlipak MG
Kidney360; 2024 May; 5(5):690-697. PubMed ID: 38472135
[TBL] [Abstract][Full Text] [Related]
12. Markers of Kidney Tubule Dysfunction and Major Adverse Kidney Events.
Bullen AL; Fregoso A; Ascher SB; Shlipak MG; Ix JH; Rifkin DE
Nephron; 2023; 147(12):713-716. PubMed ID: 37524063
[TBL] [Abstract][Full Text] [Related]
13. Prevention of heart failure events with intensive versus standard blood pressure lowering across the spectrum of kidney function and albuminuria: a SPRINT substudy.
Vaduganathan M; Pareek M; Kristensen AMD; Biering-Sørensen T; Byrne C; Almarzooq Z; Olesen TB; Olsen MH; Bhatt DL
Eur J Heart Fail; 2021 Mar; 23(3):384-392. PubMed ID: 33448580
[TBL] [Abstract][Full Text] [Related]
14. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
Potok OA; Ix JH; Shlipak MG; Katz R; Hawfield AT; Rocco MV; Ambrosius WT; Cho ME; Pajewski NM; Rastogi A; Rifkin DE
Am J Kidney Dis; 2020 Dec; 76(6):765-774. PubMed ID: 32682697
[TBL] [Abstract][Full Text] [Related]
15. Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria:
Chang AR; Kramer H; Wei G; Boucher R; Grams ME; Berlowitz D; Bhatt U; Cohen DL; Drawz P; Punzi H; Freedman BI; Haley W; Hawfield A; Horwitz E; McLouth C; Morisky D; Papademetriou V; Rocco MV; Wall B; Weiner DE; Zias A; Beddhu S;
Clin J Am Soc Nephrol; 2020 Aug; 15(8):1121-1128. PubMed ID: 32669306
[TBL] [Abstract][Full Text] [Related]
16. Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Chen Y; Zelnick LR; Huber MP; Wang K; Bansal N; Hoofnagle AN; Paranji RK; Heckbert SR; Weiss NS; Go AS; Hsu CY; Feldman HI; Waikar SS; Mehta RC; Srivastava A; Seliger SL; Lash JP; Porter AC; Raj DS; Kestenbaum BR;
Am J Kidney Dis; 2021 Aug; 78(2):226-235.e1. PubMed ID: 33421453
[TBL] [Abstract][Full Text] [Related]
17. Kidney Tubulointerstitial Fibrosis and Tubular Secretion.
Garimella PS; Katz R; Waikar SS; Srivastava A; Schmidt I; Hoofnagle A; Palsson R; Rennke HG; Stillman IE; Wang K; Kestenbaum BR; Ix JH
Am J Kidney Dis; 2022 May; 79(5):709-716. PubMed ID: 34571064
[TBL] [Abstract][Full Text] [Related]
18. Association of Urine Biomarkers of Kidney Tubule Injury and Dysfunction With Frailty Index and Cognitive Function in Persons With CKD in SPRINT.
Miller LM; Rifkin D; Lee AK; Kurella Tamura M; Pajewski NM; Weiner DE; Al-Rousan T; Shlipak M; Ix JH
Am J Kidney Dis; 2021 Oct; 78(4):530-540.e1. PubMed ID: 33647393
[TBL] [Abstract][Full Text] [Related]
19. Influence of Prediabetes on the Effects of Intensive Systolic Blood Pressure Control on Kidney Events.
Rathi N; Whelton PK; Chertow GM; Cushman WC; Cheung AK; Wei G; Boucher R; Kimmel PL; Bress AP; Kramer HJ; Al-Marji C; Greene T; Beddhu S
Am J Hypertens; 2019 Nov; 32(12):1170-1177. PubMed ID: 31257407
[TBL] [Abstract][Full Text] [Related]
20. Dipping Status, Ambulatory Blood Pressure Control, Cardiovascular Disease, and Kidney Disease Progression: A Multicenter Cohort Study of CKD.
Borrelli S; Garofalo C; Gabbai FB; Chiodini P; Signoriello S; Paoletti E; Ravera M; Bussalino E; Bellizzi V; Liberti ME; De Nicola L; Minutolo R
Am J Kidney Dis; 2023 Jan; 81(1):15-24.e1. PubMed ID: 35709922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
